2024-11-08
The AlfaMedX platform applies AI technology to the development of cell culture media formulations, establishing a media formulation algorithm platform to develop media suitable for cell growth, protein expression, and cell differentiation, including basal media, fed-batch media, and perfusion media.
Attributes of AlfaMedX
· Defined chemical composition of the
culture media and free from any animal-derived components.
· Contains amino acids, vitamins, glucose,
lipids, inorganic salts, and trace elements; free from growth factors, cholesterol,
peptides, hydrolysates, and phenol red.
· The dry powder culture media
contains P188 and HT, without L-glutamine.
Advantages of AlfaMedX
High Titer
· Protein
expression is comparable to or better than commercial culture media.
· Titer≥75% commercial
culture media.
Optimal Optimization
· Titer
can be optimized to the maximum by utilizing the #AlfaOPA culture media
optimization platform.
Cost-effective
· Shortens
product development cycle
· Significantly
reduces initial investment for customer
Adaptable
· Good
universality
· Suitable
for cell line culturing of various products

Accepted for Both Oral Presentation and Poster! Two Great Bay Bio Technology Advancements Enabling Antibody R&D for Obesity Targets Selected for Obesity Week® 2026
2026-08-12

AlfaCell Platform Enables Client’s Out-Licensed Pipeline to Successfully Enter Phase II Clinical Trials, Advancing Novel Drugs and Biosimilars in Parallel
2026-08-07

Platform Case | AI Tackles Challenging GPCR Drug Target in 8 Months! AlfaBodY Platform of Great Bay Bio Generates Long-Acting Non-Rebound Weight-Loss Antibody; Research Findings Published
2026-07-17